Natixis’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-120,609
| Closed | -$1.22M | – | 1036 |
|
|
2023
Q4 | $1.22M | Buy |
+120,609
| New | +$1.22M | 0.01% | 474 |
|
|
2023
Q3 | – | Sell |
-2,623
| Closed | -$21.6K | – | 1006 |
|
|
2023
Q2 | $21.6K | Sell |
2,623
-43
| -2% | -$354 | ﹤0.01% | 876 |
|
|
2023
Q1 | $19.3K | Hold |
2,666
| – | – | ﹤0.01% | 858 |
|
|
2022
Q4 | $23.6K | Buy |
+2,666
| New | +$23.6K | ﹤0.01% | 911 |
|
|
2022
Q2 | – | Sell |
-84,666
| Closed | -$1.61M | – | 1105 |
|
|
2022
Q1 | $1.61M | Sell |
84,666
-127
| -0.1% | -$2.42K | 0.01% | 796 |
|
|
2021
Q4 | $2.25M | Hold |
84,793
| – | – | 0.01% | 743 |
|
|
2021
Q3 | $3.48M | Sell |
84,793
-8,366
| -9% | -$344K | 0.01% | 617 |
|
|
2021
Q2 | $5.28M | Sell |
93,159
-10,728
| -10% | -$608K | 0.02% | 371 |
|
|
2021
Q1 | $4.36M | Buy |
+103,887
| New | +$4.36M | 0.01% | 541 |
|